Using cannabis for medical purposes is a practice with ancient origins. Most US states recognize the effects cannabis has on lessening cancer symptoms and increasing the quality of life of cancer patients. However, as early as the 1950s, studies began showing that cannabinoids actually have anti-tumor properties. Evidence has suggested that cannabis molecules can decrease tumor growth by modulating key cell-signaling pathways involved in the control of cancer cell proliferation and survival. Additionally, cannabinoids have been seen to reduce the metastasis of various tumor types.
At UNIFONTIS, we treat cancer with Dexanabinol, a form of synthetic cannabis. This synthetic variant may be administered intravenously to increase its benefits. Dexanabinol may be given alone or in tandem with other innovative therapies.